0001181431-13-006301.txt : 20130204 0001181431-13-006301.hdr.sgml : 20130204 20130204135747 ACCESSION NUMBER: 0001181431-13-006301 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130131 FILED AS OF DATE: 20130204 DATE AS OF CHANGE: 20130204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bahrt Kenneth CENTRAL INDEX KEY: 0001527197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13569323 MAIL ADDRESS: STREET 1: ONE TOWER CENTER BLVD CITY: EAST BRUNSWICK STATE: NJ ZIP: 08619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd368607.xml BAHRT FORM 4 X0306 4 2013-01-31 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001527197 Bahrt Kenneth 400 CROSSING BLVD. 3RD FLOOR BRIDGEWATER NJ 08807 0 1 0 0 SVP, Chief Medical Officer Common Stock $.01 par value per share 2013-01-31 4 S 0 1300 1.03 D 200750 D These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax witholding obligations in connection with the vesting of restricted stock granted on July 31, 2011 /s/ Philip K. Yachmetz as attorney-in-fact for Kenneth Bahrt 2013-02-04